Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,444.00    4.00 (0.28%)
Bid:
1,442.00
Ask:
1,448.00
Spread: 6.00 (0.416%)
Market Cap: £494.38m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Trading Statement

11 Jan 2008 07:01

Craneware plc11 January 2008 Craneware plc ("Craneware" or the "Company") H1 TRADING UPDATE 11 January 2008 - Craneware plc, (AIM: CRW) a leader in revenue cyclemanagement software solutions for the US healthcare market, is pleased to givean update today on trading during the half year to 31 December 2007. Following the Company's IPO on AIM in September 2007, Craneware has executed onits strategy to further advance its market leading position. In the six monthsto 31 December 2007, the Company signed up 96 new hospitals, compared to 64 inthe previous corresponding period. As a result, the Company's software is nowbeing used in 878 hospitals in the US, up from 800 at the beginning of the year. Revenue for the first half of the year was in line with management expectations,with new sales bookings being over 50% higher than the previous correspondingperiod. Craneware's flagship product, Chargemaster Toolkit(R), was also onceagain named top in its class by the prestigious industry research house KLAS inthe US. As stated at the time of the IPO, the Company believes there is a significantopportunity to sell additional software products into its customer base and assuch has added two further products to its suite aimed at the finance departmentof US hospitals. In November, Craneware launched Patient Charge Estimator(TM),which enables hospitals to efficiently and accurately provide prospectivepatients with estimates of procedural charges. Yesterday the Company launchedPharmacy ChargeLink(TM) which enables hospitals to improve the buying, billing and reimbursement of pharmacy items. Craneware has started the second half of the year with a strong pipeline ofsales prospects and this together with the new product launches gives managementconfidence for the Company's performance for the full year. Overall, significantprogress has been made in H1 and the Company anticipates further positivenewsflow in H2. Craneware will be announcing Interim results on Tuesday 26thFebruary 2008. Keith Neilson, CEO of Craneware, commented, "We are delighted with the progressmade during the first few months of life as a public company. Cranewarecontinues to grow and we have maintained our leading position as a provider ofrevenue cycle management software to US hospitals. The complexity of legislationgoverning this sector, and the high proportion of hospitals still using manualsolutions to manage their revenue cycles, means we are operating in a vibrantmarketplace with opportunity for growth alongside continuing high levels ofcontract renewals. We look forward to updating shareholders in February." For further information, please contact: Craneware plc KBC Peel Hunt ICIS+44 (0)1506 407 666 +44 (0)20 7418 8900 +44 (0)20 7651 8688Keith Neilson, CEO Oliver Scott Tom MoriartySandy McDougall, CFO Deon Veldtman Caroline Evans-Jones About Craneware Founded in 1999, Craneware has headquarters in Livingston, Scotland, withoffices in Florida, Arizona and Kansas, employing approximately 100 staff. TheCompany's flagship product, Chargemaster Toolkit(R) ("CMT"), assists UShealthcare providers in reducing billing errors, ensuring the timely andaccurate submission of claims and managing compliance risk. More informationabout Craneware plc and its services can be found on-line at the Company'scorporate website, www.craneware.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jul 20127:00 amRNSTrading Update
15th Jun 201210:57 amRNSTotal Voting Rights
31st May 201212:32 pmRNSHolding(s) in Company
29th May 20121:03 pmRNSHolding(s) in Company
28th May 20124:14 pmRNSHolding(s) in Company
28th May 20124:11 pmRNSHolding(s) in Company
8th May 20125:41 pmRNSHolding(s) in Company
27th Apr 20125:09 pmRNSHolding(s) in Company
26th Apr 20124:17 pmRNSHolding(s) in Company
26th Apr 20123:46 pmRNSHolding(s) in Company
23rd Apr 20126:14 pmRNSTotal Voting Rights
23rd Apr 20126:13 pmRNSBlocklisting Interim Review
16th Apr 201212:57 pmRNSHolding(s) in Company
30th Mar 201212:36 pmRNSHolding(s) in Company
29th Mar 20125:02 pmRNSHolding(s) in Company
28th Mar 20123:39 pmRNSHolding(s) in Company
20th Mar 201212:12 pmRNSHolding(s) in Company
12th Mar 20125:51 pmRNSDividend Currency Election
8th Mar 201212:57 pmRNSHolding(s) in Company
5th Mar 201212:17 pmRNSTotal Voting Rights
2nd Mar 20123:24 pmRNSHolding(s) in Company
29th Feb 20125:43 pmRNSHolding(s) in Company
28th Feb 20124:29 pmRNSDirector/PDMR Shareholding
28th Feb 20127:00 amRNSChannel Partner Contract Win
28th Feb 20127:00 amRNSHalf Yearly Report
17th Feb 20123:29 pmRNSHolding(s) in Company
1st Feb 20127:00 amRNSNotice of Results
31st Jan 201210:00 amRNSHolding(s) in Company
16th Jan 20123:40 pmRNSHolding(s) in Company
12th Jan 20126:28 pmRNSHolding(s) in Company
11th Jan 20124:55 pmRNSHolding(s) in Company
10th Jan 20127:00 amRNSTrading Update
11th Nov 20111:14 pmRNSDividend Currency Election
10th Nov 201110:36 amRNSResult of AGM
10th Nov 20117:00 amRNSAGM Statement
1st Nov 20115:39 pmRNSTotal Voting Rights
1st Nov 201112:29 pmRNSBlocklisting Interim Review
25th Oct 20111:42 pmRNSDirector/PDMR Shareholding
18th Oct 20112:26 pmRNSPosting of Annual Report & Notice of AGM
30th Sep 20114:43 pmRNSTotal Voting Rights
26th Sep 20117:00 amRNSGrant of Options
31st Aug 201111:53 amRNSDirector/PDMR Shareholding
30th Aug 20117:00 amRNSFinal Results
22nd Aug 20115:02 pmRNSHolding(s) in Company
22nd Aug 20114:40 pmRNSSecond Price Monitoring Extn
22nd Aug 20114:35 pmRNSPrice Monitoring Extension
19th Aug 20114:40 pmRNSSecond Price Monitoring Extn
19th Aug 20114:35 pmRNSPrice Monitoring Extension
11th Aug 20113:49 pmRNSHolding(s) in Company
19th Jul 20117:00 amRNSTrading Update and Contract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.